Learn More
Bio X Cell InVivoSIM anti-human HER2 (Trastuzumab Biosimilar), 25 mg
Supplier: Bio X Cell SIM0005R025MG
This biosimilar antibody is designed for preclinical research, offering high purity and low endotoxin levels suitable for in vivo applications. It targets human HER2 and provides a cost-effective solution for researchers studying Trastuzumab.
- High purity and low endotoxin
- Preservative-free formulation
- Suitable for in vivo preclinical research
- Cost-effective solution for research
- Targets human HER2
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.